+84 8 6299 2020 Account Opening | Fund NAV Board | Career | Contact

RONGVIET OUR BUSINESS RESEARCH INFORMATION INVESTOR RELATIONS SUPPORT Introduction Chairmans Message Milestones Organizational Structurec Founders Management Team Board of Directors Board of Supervisors Board of Management Network Culture & Media RongViet Culture Media Awards & Recognition Career Path RongViet Environment Human Resource Policies Recruitment Process Vacancy Information Online Application Retail Clients Brokerage & Investment Advisory Securities Services Cash Management Securities Deposit Auctions Shareholder Management Fund Certificate Distribution Research Services Financial Services Stock Mortgage Cash Advance Margin Trading Margin M+ Institutional Clients Securities Brokerage & Services Research Services Financial Services Investment Banking Capital Market Services Debt Market Services Corporate Restructuring and Valuation Compliance Services Merger & Acquisition Services Highlight Clients Promotions Value Client Program Rules Special treatments Other Programs Gift List Technical Views Recommendations 6PM Call Company Reports Strategic Reports Special Reports Stock Market Reports Report Find Analyst pinboard RongViet News Announcements Entitlements Auctions Our Partners News Investment Tools Stock Information Disclosures Disclosured Information Shareholder Information Financial Information Key Financials Annual Reports & Prospectus Corporate Governance Investor Guidance Account Opening Account Management Cash Management Securities Management Information Management Authorization Management Transaction Guidance Financial Services Margin Trading Cash Advance Stock Mortgage Auctions Client Feedbacks Fee Schedule Securities Transactions Financial Services Custody Services Other Services

News Events Trading Data Stock screener Compare stocks Technical chart analysis Enterprise 360 Research Report Central Phamaceutical Joint Stock Company No3 (HNX: DP3 ) Central Phamaceutical Joint Stock Company No3 Sector: Manufacturing Industry: Chemical - Pharmaceutical Open High Low Vol Market Cap. Remain Bid Remain Ask 52Wk High 52Wk Low 52Wk Avg Vol Frgn Buy Frgn Owned(%) Dividend Dividend Yield Beta EPS P/E F P/E BVPS P/B 1 day | 5 days | 3 months | 6 months | 12 months     Overview   Profile   Trading Data   Technical Analysis   Financials   News & Events   Documents   Compare   History price Date Price Change Volume Avg. Buy Avg. Sell Foreign Buy Foreign Sell 15/01/21 89,000 +5,000 ▲(5.95%) 20,000 1,950 2,350 11,500 - 14/01/21 84,000 -4,000 ▼(-4.55%) 12,840 775 1,250 4,700 100 13/01/21 88,000 -500 ▼(-0.56%) 4,701 464.29 746.15 3,600 - 12/01/21 88,500 0 ■(0.00%) 2,800 400 1,092.86 500 - 11/01/21 88,500 -1,500 ▼(-1.67%) 300 227.27 676.19 100 - Financials   Quarterly     Annual     Planned Targets   Loading... Loading... Loading... Industry Peers ()   HoSE  |   HNX Number of companies : 42     News   21/10/20 DP3: Financial Statement Quarter 3/2020   17/08/20 DP3: Reviewed financial statement 2020   21/07/20 DP3: Financial Statement Quarter 2/2020   20/07/20 DP3: Corporate Governance Report (first 06 months)   07/07/20 DP3: Signing of auditing contract 2020   29/06/20 DP3: Annual General Mandate 2020   16/06/20 DP3: Invitation letter to the Annual General Meeting of Shareholders of 2020   Download documents    10/21/20 DP3: FS Quarter 3 of 2020    08/17/20 DP3: Reviewed FS the first 6 month of 2020    07/21/20 DP3: FS Quarter 2 of 2020    07/16/20 DP3: Corporate Governance Report the first 6 month of 2020    06/24/20 DP3: Resolution of Annual Shareholders' Meeting 2020   Overview Contact Listing Inf. Business Reg. Additional Inf. Events Notes Name Central Phamaceutical Joint Stock Company No3 English Name Central Phamaceutical Joint Stock Company No3 Abbreviation FORIPHARM Address 16 Lê Đại Hành - Q.Hồng Bàng - Tp.Hải Phòng Telephone (Tel) (84.225) 384 2218 Fax (84.225) 382 3125 Email foripharm@hn.vnn.vn Website http://duocphamtw3.com/ Exchange HNX Sector Manufacturing Industry Chemical - Pharmaceutical Listing date 07/17/2015 Chartered capital 86,000,000,000 Shares listed 8,600,000 Shares outstanding 8,600,000 Status Operating Tax code 0200572501 Establishment License Issued date 09/15/2006 Business license 0200572501 Issued date 12/01/2003 Main business scope - Producing and trading in pharmaceutical, chemical, cosmetics, food nutrition - Business, aquaculture, processing medicinal herbs ... - 1962: Central Pharmaceutical Enterprise No.3 was established under the Ministry of Health; - 2003: Changed to Foripharm Central Pharmaceutical Joint Stock Company; - 2006: Renamed as Central Pharmaceutical Joint Stock Company No 3 with the initial charter capital of VND7.5 billion; - 2007: Increased the charter capital to VND25 billion; - 2010: Increased the charter capital to VND35 billion; - 2013: Increased the charter capital to VND52.5 billion; - 2015: Listed on Ha Noi Stock Exchange (HNX); - 12/04/2016: Increased the charter capital to VND68 billion; 23/06/2020 09:00 DP3 General Meeting of Shareholders for 2020 Location : No.28 - 351 Street - Quynh Hoang Province- Nam Son Village - An Duong Town - Hai Phong City 03/06/2020 09:00 DP3 Dividend payment in cash with 70.00% for 2019 (Record date) Location : Securities Companies 03/06/2020 09:00 DP3 Dividend payment in cash with 70.00% for 2019 Location : Securities Companies Items Unit Price VND Volume Shares Foreigner's, Yield % Mkt Cap bVND Financial indicators mVND EPS, BVPS, Dividend VND P/E, F P/E, P/B Times ROS, ROA, ROE %  1. The accounting period for equitization year was calculated as of company's establishment date. 2. F PE bases on corporate earnings targets, which are announced by listed companies. 3. 3-month/6-month/12-month price charts was was compiled from revised data.

Terms of usage | View counts: 4233981 | Online viewers: 20 ©Copyrights 2015 - RongViet Sercurities Corporation | | Bloomberg: VDSC < GO >